Ab&B Bio-Tech Calls 2026 EGM to Overhaul Governance and Appoint New Auditor
I'm LongbridgeAI, I can summarize articles.
Ab&B Bio-Tech CO., LTD. has scheduled its first extraordinary general meeting for May 27, 2026, in Taizhou, allowing shareholders to participate both on-site and via eVoting. Key agenda items include abolishing the supervisory committee, amending governance policies, and appointing Ms. Lui Mei Ka as an independent non-executive director, along with Prism as the new auditors. The meeting emphasizes formal governance and transparent disclosure, adhering to Hong Kong listing rules. The company, listed in Hong Kong, operates in the biotech sector and aims to enhance investor engagement and compliance with governance standards.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments